New registry tracks Real-World use of kidney anemia drug
NCT ID NCT07346547
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is a registry that will collect information from 384 adults with chronic kidney disease (CKD) and anemia who are taking or starting the drug daprodustat. The goal is to understand how the drug works in everyday medical practice, including its effects on hemoglobin levels and heart health. The study does not test a new treatment but observes real-world outcomes to improve care and guidelines.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CKD ANEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.